MSDC 0160 T2607
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MSDC-0160 is a prototype mTOT-modulating insulin sensitizer being used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.
CAS nr:
146062-49-9
Purity:
98%
Molecular Weight:
370,42
SMILES:
CCc1cnc(cc1)C(=O)COc1ccc(cc1)CC1C(=O)NC(=O)S1
Formula:
C19H18N2O4S
Pathway:
Metabolism,Others,Tyrosine Kinase/Adaptors
Target:
Mitochondrial Metabolism,Others,IGF-1R
